Press launch MHRA approves GLP –1 receptor agonist semaglutide to lessen threat of serious heart troubles in obese or overweight Older people Semaglutide is the very first weight reduction drug permitted in the united kingdom as a preventative procedure for those with proven cardiovascular diseaseBefore applying Wegovy®, explain to your Health c